**Core tip:** At present, all medical centers choose cuffs based on the experience of the surgeon, without quantitative criteria. We report how the intraoperative urethral pressure profilometry can be performed by combining the T-DOC air-charged catheter and ambulatory urodynamic equipment to guide the selection and adjustment of cuffs. By comparing the effect of intraoperative urethral pressure on postoperative urinary continence, we can establish the relationship between the range of intraoperative urethral pressure and its effect on urinary continence to guide clinical diagnosis and treatment and to standardize artificial urethral sphincter implantation.

INTRODUCTION
============

Urinary incontinence is a common complication of prostate surgery for treatment of prostate cancer or benign prostatic hyperplasia (BPH), which can significantly affect the quality of life of patients.

The International Continence Society (ICS) defines urinary incontinence after prostate surgery as the unconscious leakage of urine following prostate surgery, with or without bladder dysfunction\[[@B1]\]. Currently, about 22.6 million men worldwide suffer from urinary incontinence, 12.5% of whom have simple stress urinary incontinence\[[@B2]\], and most of whom have a history of prostate surgery, nerve injury, or trauma. According to related literature, the rate of incontinence is 1% among patients after transurethral resection of the prostate (TURP) and 2%-57% after radical prostatectomy\[[@B3]-[@B5]\].

Artificial urethral sphincter (AUS) implantation has become the gold standard for treatment of moderate to severe urinary incontinence and urinary incontinence due to impaired sphincter function\[[@B6]\]. Before the operation, urodynamic and cystoscopic examinations are recommended to assess bladder and urethral function and to ensure anatomical stability of the bladder and urethra\[[@B2],[@B7]\]. However, there have been few studies on the maximum urethral pressure (MUP) and maximum urethral closure pressure (MUCP) when an AUS is implanted and activated\[[@B8],[@B9]\]. To the best of our knowledge, no literature has reported the changes in MUP and MUCP before, during, and after implantation and activation of an AUS. This article reports the diagnosis and treatment of a patient with urinary incontinence after TURP, admitted to our hospital in March 2019.

CASE PRESENTATION
=================

Chief complaints
----------------

A 67-year-old Chinese man was admitted to our hospital complaining of postoperative urinary leakage and incontinence for 11 mo.

History of present illness
--------------------------

The man was diagnosed with BPH following frequent urination and dysuria in April 2018. TURP was performed in the same month, and no malignant lesions were found. He had not undergone any previous surgeries. After removal of the catheter, unconscious leakage of urine was observed. Oral medicine, behavioral therapy, and other conservative treatments were ineffective. Up until presentation, urinary incontinence had gradually increased. The clinical manifestation was continuous leakage of urine; therefore, the patient was using five pads/d to ensure local dryness.

History of past illness
-----------------------

In April 2018, TURP was performed in the hospital due to BPH; the patient denied any history of other diseases and allergies.

Personal and family history
---------------------------

No smoking or drinking history was reported; no genetic family medical history was reported.

Physical examination upon admission
-----------------------------------

Physical examination showed continuous leakage of urine but no sign of redness, swelling, or eczema on the skin around the penis.

Laboratory examinations
-----------------------

Laboratory findings were unremarkable.

Imaging examinations
--------------------

Routine examination, cystoscopy, urodynamics, and urethral pressure profilometry were performed. During cystoscopy, no urethral stricture was observed; however, the urethra showed incomplete closure (Figure [1A](#F1){ref-type="fig"}). Urodynamics and urethral pressure profilometry showed normal bladder function and compliance. The MUP was 52 cmH2O and MUCP was 17 cmH2O (Figure [1B](#F1){ref-type="fig"}).

![Preoperative examination. A: Cystoscopy revealed no urethral stricture, and it was observed that the urethra could not close completely; B: Preoperative urethral pressure profilometry showed that the maximum urethral pressure was 52 cmH2O and maximum urethral closure pressure was 17 cmH2O.](WJCC-7-4084-g001){#F1}

FINAL DIAGNOSIS
===============

Post-prostatectomy urinary incontinence.

TREATMENT
=========

AUS implantation through a single perineal incision was performed in March 2019. When measured intraoperatively, the bulbourethral circumference was 6 cm. However, the general circumference of the urethra in Chinese men is usually 4.0-4.5 cm. Considering the height, weight, and general condition of the patient, we could not rule out the possibility of increased urethral circumference being related to abnormal erection and congestion of the periurethral tissue during operation (Figure [2A](#F2){ref-type="fig"}). Finally, under the guidance of the engineer assisting the surgeon, a 4.5-cm cuff was selected and placed (Figure [2B](#F2){ref-type="fig"}).

![Intraoperative findings. A: Abnormal erection during operation; B: A 4.5-cm cuff was selected and placed; C: During operation, the maximum urethral pressure (MUP) was 53 cmH2O and maximum urethral closure pressure (MUCP) was 50 cmH2O in the inactivated state; the MUP was 112 cmH2O and MUCP was 109 cmH2O in the activated state.](WJCC-7-4084-g002){#F2}

Urethral pressure profilometry was performed after connecting the entire device on inactivation and activation. In the inactivated state, MUP and MUCP were 53 cmH2O and 50 cmH2O, respectively, while in the activated state, MUP and MUCP were 112 cmH2O and 109 cmH2O, respectively (Figure [2C](#F2){ref-type="fig"}).

On the postoperative day 1, the catheter was removed, and urine continued to flow out. The patient was discharged on postoperative day 5. Six weeks after the operation, the patient returned to the hospital for a checkup and activation of the pump. Urodynamics and urethral pressure were measured again. In the inactivated state, the MUP and MUCP were 89 cmH2O and 51 cmH2O, respectively, while in the activated state, MUP and MUCP were 120 cmH2O and 92 cmH2O, respectively (Figure [3](#F3){ref-type="fig"}).

![Urethral pressure measured at follow-up. Six weeks after the operation, the maximum urethral pressure (MUP) was 89 cmH2O and maximum urethral closure pressure (MUCP) was 51 cmH2O in the inactivated state; the MUP was 120 cmH2O and MUCP was 92 cmH2O in the activated state.](WJCC-7-4084-g003){#F3}

Standard urodynamic equipment (Laborie Delphis, Laborie Medical Technologies Canada unlimited liability corporation) and a 7-Fr air sensor (air-charged dual sensor catheter) were used to perform the urodynamic test and urethral pressure profilometry before the operation. The tractor pulls out the catheter at a uniform speed of 1 mm/s. Intraoperative and postoperative urethral pressure measurements were performed using an ambulatory urodynamic device (Laborie, Laborie Medical Technologies Canada unlimited liability corporation) and a 7-Fr air-charged catheter.

After the cuff of the artificial sphincter was closed, we recorded the MUP and MUCP. Thereafter, MUP and MUCP were recorded with the cuff open.

The definitions used in this article are in line with the recommendations of the ICS\[[@B10]\].

OUTCOME AND FOLLOW-UP
=====================

One month after device activation, telephonic follow-up revealed that pad use by the patient decreased from the previous five pads/d to one pad/d to maintain local dryness, reaching the standard social urinary continence of 0-1 pad per day.

DISCUSSION
==========

This report shows how intraoperative urethral pressure profilometry is performed using a T-DOC air-charged catheter with ambulatory urodynamic equipment to guide cuff selection and adjustment.

For many years, AUS has been regarded as the most effective long-term treatment for male urinary incontinence. For over 10 years, AUS has been the first choice for treating permanent urinary incontinence after prostatectomy in European and American countries\[[@B11],[@B12]\]. The implantation of AUS is not complicated. The key to a successful operation is to choose the appropriate cuff size; however, there is no standardized guide for choosing cuff size. The choice of cuff size during operation mainly depends on the measured urethral circumference of the patient. Traditionally, it is agreed that too small a cuff may increase the risk of urethral atrophy and erosion; however, too large a cuff may not achieve the desired control on urine continence and lead to recurrence or persistence of urinary incontinence. At present, all medical centers choose cuffs based on the surgeon's experience, without quantitative criteria. Unfortunately, this cannot accurately predict the effectiveness of urinary control nor the risk of complications.

These factors restrict the application of AUS; however, they also provide ideas for our research. In the past, urodynamic instruments were bulky and inconvenient to move. The traditional water-perfused catheter for measuring urethral pressure had strict requirements regarding patient position; it could only measure pressure in one direction, and the accuracy and repeatability were not high\[[@B13]\]. All these factors make it difficult for us to accurately measure urethral pressure during the operation. The emergence of ambulatory urodynamic equipment and the T-DOC air-charged catheter have facilitated cuff size measurement. Research on the T-DOC air-charged catheter has proved that it is not inferior to other catheters, such as traditional water-perfused catheters and microtransducer urodynamic catheters, in urethral pressure measurement; the T-DOC air-charged catheter measures the average pressure in a 360-degree environment, which is more readable\[[@B14]-[@B16]\]. This is the innovation in our study. We were able to measure the intraoperative urethral pressure, which can provide specific values of intraoperative MUP and MUCP and compare the postoperative continence of patients so that the clinical effects of different urethral pressures can be analyzed. In the future, we aim to determine the relationship between specific ranges of urethral pressure and the measure of urinary control by comparing data among more patients. This will further guide the clinical diagnosis and treatment of urinary incontinence and standardize AUS implantation. Similarly, this method can also be used in patients with stress urinary incontinence undergoing sling surgery. Regardless of the procedure, AUS or sling operation, the measure of urine control after operation is closely related to the individual experience of the surgeon, and there is no quantitative standard.

Although the methodology of urethral pressure measurement is standardized, to our knowledge, there are no generally accepted reference values for a healthy state. Chinese experts have reported that the average MUP of a normal elderly Chinese man is 77 (55-105) cmH2O, and the reference range of MUCP is 60-80 cmH2O\[[@B17]\]. In this study, the MUP of the patient before surgery and in the states of intraoperative activation and inactivation and postoperative activation and inactivation were 52, 112, 53, 120, and 89 cm H2O, respectively, and MUCP was 17, 109, 50, 92, and 51 cm H2O, respectively. The measure of urine control was satisfactory, and no complications related to the operation were found during the 1-mo follow-up appointment.

The purpose of AUS implantation is to acquire the ability to control urinary incontinence, to achieve the standard of social continence (0-1 pads/d), and to minimize the occurrence of complications. Therefore, it is logical to evaluate the changes in urethral pressure in patients after AUS implantation. Ripert et al\[[@B18]\] studied the changes in urethral pressure in patients after AUS implantation. He enrolled 27 patients who underwent AUS implantation from 2012 to 2014 and maintained social continence at the time of follow-up. Urethral pressure was measured. MUP in all the patients was greater than 70 cmH2O, and in 22 (81.48%) patients MUP was greater than 90 cmH2O. The mean MUP was 119.55 (77-180) cmH2O, and the mean MUCP was 88.29 (32-160) cmH2O. In addition, Lowe et al\[[@B8]\] included 24 male patients who underwent AUS implantation and were followed with urinary control for at least one year after operation. They analyzed the results combined with the measurement of urethral pressure. The study found that the MUCP of all patients was above 65 cmH2O; however, there were still eight patients with recurrence of moderate to severe urinary incontinence; the average MUCP was 76.9 cmH2O. It was presumed that the cuff may only be slightly attached to the urethra; it provides higher urethral closure pressure only when the urethral pressure exceeds 100 cmH2O. At the same time, if a larger cuff is used, the pressure transmitted to the urethra decreases accordingly. Therefore, when choosing the cuff, doctors can choose a smaller cuff to make it more suitable for the urethra; however, they should pay attention to the risk of complications, such as urethral erosion. The results obtained in the above study are consistent with the present study and provide a theoretical basis for the present study. However, a smaller cuff may lead to increased MUP; if it does not affect the patient\'s urinary flow rate, we think it is more appropriate.

To conclude, in the later stage, we can achieve the container zone through this method. If the intraoperative MUCP is lower than the lowest value of the interval, it indicates that the cuff size is too large and should be replaced with a smaller one. If the intraoperative MUCP is higher than the highest value of the interval, it should be considered whether removal of the periurethral tissue is satisfactory. If the removal is not satisfactory, the excess tissue should then be removed. If the removal of the excess tissue is satisfactory, the cuff with a larger size should be replaced to obtain satisfactory clinical effect and reduce the incidence of complications.

One limitation of this study is that, when measuring urethral pressure during and after operation, the catheter was pulled manually and uniformly, which may have caused a certain degree of error. In addition, the follow-up time was short, and the long-term clinical outcomes of the patient are not known. However, with an increase in the number of patients and an extension of the follow-up period, we believe that more rigorous conclusions can be drawn to guide the clinical diagnosis and treatment of urinary incontinence.

CONCLUSION
==========

We report the first successful case of intraoperative urethral pressure management. By comparing the effect of intraoperative urethral pressure on postoperative urinary continence, we can determine the relationship between the range of intraoperative urethral pressure and its effect on urinary continence. This will help guide the clinical diagnosis and treatment of urinary incontinence as well as standardize the AUS implantation procedure.
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